Prevalence and risk factors for depressive symptoms in patients with neovascular age-related macular degeneration who present for anti-VEGF therapy.
Kim Van VuPaul MitchellHarshil Dharamdasani DetaramGeorge BurlutskyGerald LiewBamini GopinathPublished in: Acta ophthalmologica (2020)
A high prevalence of depressive symptoms was observed among nAMD patients presenting for treatment. Poorer SRH, ADL impairment and reduced visual function were associated with increased odds of depressive symptoms.
Keyphrases
- depressive symptoms
- age related macular degeneration
- social support
- end stage renal disease
- ejection fraction
- sleep quality
- newly diagnosed
- chronic kidney disease
- vascular endothelial growth factor
- prognostic factors
- peritoneal dialysis
- endothelial cells
- mesenchymal stem cells
- combination therapy
- cell therapy
- patient reported